Stocks-INGN-Inogen Inc

INGN Inogen Inc

9.12 -0.13 (-1.41%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Stocks-INGN-Inogen Inc
INGN Inogen Inc
Trade

Overview

Prev Close 9.12
Day's Range 9.10 - 9.38
52 Week Range 4.34 - 13.27
Average Volume (3M) 203.91K
1-Year Return 89.60%
Beta1.3366
Market Cap 216.32M
P/E Ratio-2.3
Revenue326.65M
EPS-3.9667
Dividend (Yield) 0 (0%)
Sector
Health Technology
Industry
Medical Specialties
CEO
Kevin R. Smith, MBA
Employees
834

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Inogen Inc's revenues decreased by 16.32% and amounted to 315.66M. Net income decreased by 22.30% to -102.45M. Net assets decreased by 31.13% to 204.81M and EPS decreased from -3.67 to -4.42.
INGN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
45.69%
Net Profit Margin
-10.51%
Operating Margin
-16.91%
Return On Investment
-13.92%
09/23
12/23
03/24
06/24
Total Revenue
83.97M
75.9M
78.03M
88.77M
Gross Profit
40.5M
28.16M
34.37M
42.74M
Operating Income
-11.45M
-28.98M
-16.27M
-7.06M
Net Income
-45.72M
-26.56M
-14.58M
-5.59M